150 related articles for article (PubMed ID: 27618139)
1. Significant Decrease in Plasma Levels of D-Dimer, Interleukin-8, and Interleukin-12 After a 12-Month Treatment with Rosuvastatin in HIV-Infected Patients Under Antiretroviral Therapy.
Calza L; Colangeli V; Magistrelli E; Contadini I; Bon I; Re MC; Conti M; Mancini R; Viale P
AIDS Res Hum Retroviruses; 2017 Feb; 33(2):126-132. PubMed ID: 27618139
[TBL] [Abstract][Full Text] [Related]
2. Tenofovir/emtricitabine/efavirenz plus rosuvastatin decrease serum levels of inflammatory markers more than antiretroviral drugs alone in antiretroviral therapy-naive HIV-infected patients.
Calza L; Vanino E; Salvadori C; Manfredi R; Colangeli V; Cascavilla A; Di Bari MA; Motta R; Viale P
HIV Clin Trials; 2014; 15(1):1-13. PubMed ID: 24518210
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Rosuvastatin on Plasma/Serum Levels of High-Sensitivity C-Reactive Protein, Interleukin-6, and D-Dimer in People Living with Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis.
Ashuro AA; Fan YG; Fu YS; Di DS; Sam NB; Pan HF; Ye DQ
AIDS Res Hum Retroviruses; 2021 Nov; 37(11):821-833. PubMed ID: 33913752
[TBL] [Abstract][Full Text] [Related]
4. Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-α in HIV-infected patients treated with ritonavir-boosted protease inhibitors.
Calza L; Trapani F; Bartoletti M; Manfredi R; Colangeli V; Borderi M; Grossi G; Motta R; Viale P
HIV Clin Trials; 2012; 13(3):153-61. PubMed ID: 22592095
[TBL] [Abstract][Full Text] [Related]
5. Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy.
Funderburg NT; Jiang Y; Debanne SM; Storer N; Labbato D; Clagett B; Robinson J; Lederman MM; McComsey GA
Clin Infect Dis; 2014 Feb; 58(4):588-95. PubMed ID: 24253250
[TBL] [Abstract][Full Text] [Related]
6. Effect of rosuvastatin on plasma coenzyme Q10 in HIV-infected individuals on antiretroviral therapy.
Morrison JT; Longenecker CT; Mittelsteadt A; Jiang Y; Debanne SM; McComsey GA
HIV Clin Trials; 2016 Jul; 17(4):140-6. PubMed ID: 27294339
[TBL] [Abstract][Full Text] [Related]
7. The effect of initiating combined antiretroviral therapy on endothelial cell activation and coagulation markers in South African HIV-infected individuals.
Jong E; Louw S; van Gorp EC; Meijers JC; ten Cate H; Jacobson BF
Thromb Haemost; 2010 Dec; 104(6):1228-34. PubMed ID: 20886182
[TBL] [Abstract][Full Text] [Related]
8. Rosuvastatin decreases serum inflammatory markers and slows atherosclerosis progression rate in treated HIV-infected patients with metabolic syndrome.
Calza L; Colangeli V; Borderi M; Beci G; Esposito F; Bon I; Re MC; Viale P
Infect Dis (Lond); 2021 Feb; 53(2):81-88. PubMed ID: 32955957
[TBL] [Abstract][Full Text] [Related]
9. Effect of rosuvastatin on risk markers for venous thromboembolism in cancer.
Ades S; Douce D; Holmes CE; Cory S; Prior S; Butenas S; Callas P; Cushman M
J Thromb Haemost; 2018 Jun; 16(6):1099-1106. PubMed ID: 29575637
[TBL] [Abstract][Full Text] [Related]
10. Two-year treatment with rosuvastatin reduces carotid intima-media thickness in HIV type 1-infected patients receiving highly active antiretroviral therapy with asymptomatic atherosclerosis and moderate cardiovascular risk.
Calza L; Manfredi R; Colangeli V; Trapani FF; Salvadori C; Magistrelli E; Danese I; Verucchi G; Serra C; Viale P
AIDS Res Hum Retroviruses; 2013 Mar; 29(3):547-56. PubMed ID: 23098891
[TBL] [Abstract][Full Text] [Related]
11. Effects of 96 Weeks of Rosuvastatin on Bone, Muscle, and Fat in HIV-Infected Adults on Effective Antiretroviral Therapy.
Erlandson KM; Jiang Y; Debanne SM; McComsey GA
AIDS Res Hum Retroviruses; 2016 Apr; 32(4):311-6. PubMed ID: 26477698
[TBL] [Abstract][Full Text] [Related]
12. Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death.
Boulware DR; Hullsiek KH; Puronen CE; Rupert A; Baker JV; French MA; Bohjanen PR; Novak RM; Neaton JD; Sereti I;
J Infect Dis; 2011 Jun; 203(11):1637-46. PubMed ID: 21592994
[TBL] [Abstract][Full Text] [Related]
13. Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART.
Stiksrud B; Nowak P; Nwosu FC; Kvale D; Thalme A; Sonnerborg A; Ueland PM; Holm K; Birkeland SE; Dahm AE; Sandset PM; Rudi K; Hov JR; Dyrhol-Riise AM; Trøseid M
J Acquir Immune Defic Syndr; 2015 Dec; 70(4):329-37. PubMed ID: 26258571
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-2 cycling causes transient increases in high-sensitivity C-reactive protein and D-dimer that are not associated with plasma HIV-RNA levels.
Porter BO; Shen J; Kovacs JA; Davey RT; Rehm C; Lozier J; Csako G; Nghiem K; Costello R; Lane HC; Sereti I
AIDS; 2009 Sep; 23(15):2015-9. PubMed ID: 19617815
[TBL] [Abstract][Full Text] [Related]
15. Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study).
Calza L; Magistrelli E; Colangeli V; Borderi M; Bussini L; Bon I; Re MC; Viale P
Infect Dis (Lond); 2017 Oct; 49(10):737-747. PubMed ID: 28683645
[TBL] [Abstract][Full Text] [Related]
16. Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy.
Funderburg NT; Jiang Y; Debanne SM; Labbato D; Juchnowski S; Ferrari B; Clagett B; Robinson J; Lederman MM; McComsey GA
J Acquir Immune Defic Syndr; 2015 Apr; 68(4):396-404. PubMed ID: 25514794
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
Kuller LH; Tracy R; Belloso W; De Wit S; Drummond F; Lane HC; Ledergerber B; Lundgren J; Neuhaus J; Nixon D; Paton NI; Neaton JD;
PLoS Med; 2008 Oct; 5(10):e203. PubMed ID: 18942885
[TBL] [Abstract][Full Text] [Related]
18. Rosuvastatin Worsens Insulin Resistance in HIV-Infected Adults on Antiretroviral Therapy.
Erlandson KM; Jiang Y; Debanne SM; McComsey GA
Clin Infect Dis; 2015 Nov; 61(10):1566-72. PubMed ID: 26157049
[TBL] [Abstract][Full Text] [Related]
19. Baseline Vitamin D Deficiency Decreases the Effectiveness of Statins in HIV-Infected Adults on Antiretroviral Therapy.
Hileman CO; Tangpricha V; Sattar A; McComsey GA
J Acquir Immune Defic Syndr; 2017 Apr; 74(5):539-547. PubMed ID: 28045766
[TBL] [Abstract][Full Text] [Related]
20. Rosuvastatin slows progression of subclinical atherosclerosis in patients with treated HIV infection.
Longenecker CT; Sattar A; Gilkeson R; McComsey GA
AIDS; 2016 Sep; 30(14):2195-203. PubMed ID: 27203715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
